SCHEMBL25516873

SCHEMBL25516873

CC(C)(C)OC(=O)N(CCO)Cc1cc(Cl)ccc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 1/20 0.46
HIF1A Q16665 3/20 0.41
MEN1 O00255 2/20 0.41
CYP3A4 P08684 2/20 0.41
HPGD P15428 2/20 0.41
ALOX15 P16050 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.41
SLC22A1 O15245 1/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
HSP90AA1 P07900 1/20 0.41
HSPD1 P10809 1/20 0.41
HSPA5 P11021 1/20 0.41
IDO1 P14902 1/20 0.41
ALOX12 P18054 1/20 0.41
CASP1 P29466 1/20 0.41
HTT P42858 1/20 0.41
BLM P54132 1/20 0.41
HSPE1 P61604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30174862 1.00 SSTR4 (0.46) SSTR4HIF1AMEN1CYP3A4HPGD
SCHEMBL25399749 0.91 SSTR4 (0.47) SSTR4MEN1CYP3A4HPGDALOX15
SCHEMBL7852494 0.85 SSTR4 (0.52) SSTR4HPGDUSP2LMNAHTT
SCHEMBL25516985 0.84 SSTR4 (0.50) SSTR4MEN1KMT2AHSPA5AKR1B1
SCHEMBL30174644 0.84 SSTR4 (0.50) SSTR4MEN1KMT2AHSPA5AKR1B1
SCHEMBL3942906 0.81 SSTR4 (0.44) SSTR4HIF1ACYP3A4HPGDMAPT
SCHEMBL2258889 0.81 SSTR4 (0.50) SSTR4MEN1CYP3A4KMT2ALMNA
SCHEMBL27767983 0.81 SSTR4 (0.43) SSTR4HIF1AMEN1HPGDALOX15
SCHEMBL3934276 0.80 ALDH1A1 (0.46) SSTR4HPGDKMT2AMAPTLMNA
SCHEMBL15055377 0.79 SSTR4 (0.54) SSTR4HPGDUSP2LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159453-A1 INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION COCRYSTAL PHARMA, INC. 2023-05-25 US disclosed
US-20230159453-A1 INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION COCRYSTAL PHARMA, INC. 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159453-A1 INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION VIM, ACE, ACE2 SSTR4 3440/4885HIF1A 2222/4885MEN1 1593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.